FINAL PROGRAMME ‐ 1st VITILIGO WORLD CONGRESS

Thursday, September 23rd

08.45 – 09.15 Welcome addresses
SESSION I – Vitiligo: history and clinical actuality
Chairpersons: T. Lotti, R. Spritz, J.P.W. Van der Veen, G.A. Vena
09.15 – 09.30 Classifications and clinical variants of vitiligo
J. Hercogova
09.30 – 09.45 Classification of segmental vitiligo involving the face and neck
S-K. Hann
09.45 – 10.00 Vitiligo in pediatric age
G. Fabrizi,
10.00 – 10.15 Differential diagnosis of vitiligo
A. Taïeb
10.15 – 10.30 Discussion
10.30 – 11.00  Coffee break
SESSION II – Research on vitiligo: state of play  -  part I
Chairpersons: U. Bottoni, L. Naldi, A. Peserico, M. Picardo, A. Taïeb
11.00 – 11.15 The Genetic basis of generalized vitiligo
R. Spritz
11.15 – 11.30 The POMC system in vitiligo
M. Böhm
11.30 – 11.45 PAR-2 involvement in vitiligo pathogenesis
S. Moretti
11.45 – 12.00 Inherent cellular and molecular defects in vitiligo melanocytes
R. Boissy
12.00 – 12.30 Keynote lecture
T lymphocyte-mediated melanocyte destruction in melanoma patients
G. Parmiani
12.30 – 12.45 Discussion
12.45 – 13.15 Keynote lecture
Image analysis in vitiligo assessment
L. Naldi, S. Cazzaniga
13.15 – 14.30  Lunch
SESSION III – Research on vitiligo: state of play - part II
Chairpersons: M. Böhm, R. Boissy, A. Di Pietro, S. Moretti
14.30 – 14.45 Basis and effects of the oxidative stress
M. Picardo
14.45 – 15.00 The role of nitric oxide in the pathogenesis of vitiligo: facts and hypothesis
M. Vaccaro
15.00 – 15.15 The burden of vitiligo
J.P.W. Van der Veen
15.15 – 15.30 Discussion
SESSION IV –Vitiligo through the eyes of patients
Chairpersons: S. Dattola, S.R. Mercuri, D. Parsad, W. Westerhof
15.30 – 15.45  The body on show: between health and well-being
L. Sarno
15.45 – 16.00 Quality of life in vitiligo
P. Kumarasinghe
16.00 – 16.40

Alida DePase introduces:

My life with vitiligo: the journey from patient to researcher
M. Whitton

Live your best life now
L. Thomas

16.40-16.45 Discussion
16.45 – 17.00 Coffee break
SESSION V – Complementary therapies
Chairpersons: D. Fai, S-K. Hann, N. Van Geel, G.F. Zagni
17.00 – 17.15 Vitiligo: my experience of 24 years and 18 thousand patients.
My protocol and my lotions
A. Salafia
17.15 – 17.30 When the skin changes the color: “the camouflage”
C. Rigoni, A. Cantù
17.30 – 17.45 Micropigmentation: another solution in vitiligo camouflage
M. Lardì
17.45 – 18.15 Discussion and closing remarks

Friday, September 24th

SESSION VI – Management of vitiligo
Chairpersons: S.P. Cannavò, S. Menni, D. Parsad, A. Tanew
09.00 – 09.15 Preventive and curative treatment of vitiligo, based on the integrated pathogenesis theory
W. Westerhof
09.15 – 09.30 Management of vitiligo in Czech Republic
J. Hercogova
09.30 – 09.45 Systematic review of treatment for vitiligo. What randomised trials tell us about vitiligo treatment
U. Gonzàlez
09.45 – 10.00 Evidence-based treatments of vitiligo
D. Gawkrodger
10.00 – 10.15 Evidence-based management of vitiligo. How to define priorities for clinical research
V. Eleftheriadou
10.15 – 10.30 Discussion
10.30 – 11.00 Coffee break
SESSION VII – Ultraviolets and phototherapy – part I
Chairpersons: P. Calzavara Pinton, V. Eleftheriadou, J. Hercogova, L. Mavilia, F. qRongioletti,  K.U. Schallreuter
11.00 – 11.15 Phototherapy
A. Tanew
11.15 – 11.30 Novel approaches in phototherapy of vitiligo
A. Pacifico
11.30 – 11.45 Microphototherapy
T. Lotti
11.45 – 12.00

Combined Narrow-band UVB therapy and tacrolimus ointment in the treatment of vitiligo in 40 patients
A.G. Galluccio
12.00 – 12.15 Follow-up long-term evaluation of a cohort of vitiligo patients treated with narrow-band UVB phototherapy and tacrolimus ointment
D. Fai
12.15 – 12.30 Discussion
12.30 – 13.00 Keynote lecture
Vitiligo associated organ-specific autoimmune diseases
E. Bosi
13.00 – 14.30 Lunch
SESSION VIII – Ultraviolets and Phototherapy – part II
Chairpersons: G.E. Cannata, A. G. Galluccio, U. Gonzàlez, F. Rongioletti
14.30 – 14.45 NB-UVB and topical tacrolimus: our five-years experience in vitiligo treatment
A. Baldo
14.45 – 15.00 Topical steroid combined to excimer laser in the treatment of vitiligo. Vitiligo and psoriasis in the era of biological drugs.
L. Mavilia
15.00 – 15.15 Polipodium
D. Fai
15.15 – 15.30 Dead Sea and pseudocatalase combined treatment for vitiligo   
K. Schallreuter
15.30 – 15.45 Vitiligo: effectiveness of UVB “narrow-band” plus tacrolimus 0,1%
ointment association
D. D’Amico and G. Valenti
15.45 – 16.00 Discussion
SESSION IX – Surgery and long term stability
Chairpersons: P.L. Bencini, D. Gawkrodger, S.R. Mercuri, L. Naldi, A. Salafia
16.00 – 16.15 Autologous ORS cell transplantation: adult stem therapy for vitiligo
T. Hunziker
16.15 – 16.30 Long term results of autologous transplanted epidermal cell suspensions for repigmenting vitiligo
N. Van Geel
16.30 – 16.45 Total stability and complete repigmentation in vitiligo: how close are we?      
D. Parsad
16.45 – 17.00 Discussion
17.00 – 18.30 Selected abstract
18.30 Closing remarks and presentation of the patient day